The history of copyright's flagship drug presents a interesting case for stakeholders in the drug sector. While initially a phenomenal success, generating vast sums, the patent expiration and the subsequent entry of cheaper competitors have drastically affected revenue. This poses questions about the long-term sustainability of similar drug inno… Read More